• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of new therapeutic strategies for hypoxic tumors

Research Project

Project/Area Number 18H02757
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 52040:Radiological sciences-related
Research InstitutionFukushima Medical University (2020)
Hokkaido University (2018-2019)

Principal Investigator

Shiga Tohru  福島県立医科大学, 公私立大学の部局等, 教授 (80374495)

Co-Investigator(Kenkyū-buntansha) 安井 博宣  北海道大学, 獣医学研究院, 准教授 (10570228)
竹内 啓  北海道大学, 医学研究院, 助教 (30374515)
久下 裕司  北海道大学, アイソトープ総合センター, 教授 (70321958)
趙 松吉  福島県立医科大学, 公私立大学の部局等, 教授 (80374239)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2020: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2019: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2018: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
Keywords低酸素 / 放射線治療 / PET / 化学療法 / 低酸素改善 / エリブリン / 抗腫瘍効果 / 治療効果 / 再酸素化 / 治療開発 / 治療戦略 / 低酸素イメージング
Outline of Final Research Achievements

"Does eribulin improve tumor hypoxia? "To what extent does it improve the efficacy of chemotherapy and radiotherapy? "To what extent does it improve the efficacy of chemotherapy and radiotherapy?" and "Does it improve the prognosis as a result? We planned to conduct animal experiments and clinical trials to answer these three questions.
In animal experiments using transplanted human breast cancer cells, we were able to show that 1) eribulin improves tumor hypoxia, 2) significantly slows tumor growth after radiotherapy, and 3) significantly improves survival. We also found that eribulin improved tumor oxygenation in a dose-dependent manner, with maximum oxygenation occurring 7 days after administration.
The human study was planned as a specific clinical trial, but POC was not obtained.

Academic Significance and Societal Importance of the Research Achievements

エリブリンは腫瘍の低酸素状態を容量依存的に改善し、2)放射線治療後の腫瘍の成長を有意に遅らせ、3)生存率を有意に向上させる事を示す事を動物実験で示す事が可能であった。エリブリン併用の放射線治療を行う事により、低酸素状態が強いと考えられる壊死等を伴った腫瘍に対し腫瘍縮小効果や生存率の改善がみこめる可能性がある。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Annual Research Report
  • 2018 Annual Research Report
  • Research Products

    (3 results)

All 2020 2019

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (1 results)

  • [Journal Article] Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models2019

    • Author(s)
      Zhao Songji、Yu Wenwen、Ukon Naoyuki、Tan Chengbo、Nishijima Ken-ichi、Shimizu Yoichi、Higashikawa Kei、Shiga Tohru、Yamashita Hiroko、Tamaki Nagara、Kuge Yuji
    • Journal Title

      EJNMMI Research

      Volume: 9 Issue: 1 Pages: 51-51

    • DOI

      10.1186/s13550-019-0521-x

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer2019

    • Author(s)
      Kroenke Markus、Hirata Kenji、Gafita Andrei、Watanabe Shiro、Okamoto Shozo、Magota Keiichi、Shiga Tohru、Kuge Yuji、Tamaki Nagara
    • Journal Title

      PLOS ONE

      Volume: 14 Issue: 2 Pages: e0213111-e0213111

    • DOI

      10.1371/journal.pone.0213111

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 18 F-DiFA PET/CTイメージングを用いたエリブリンによる腫瘍内低酸素解除効 果の解析と放射線増感作用の検討2020

    • Author(s)
      房知輝 、安井博宣 、志賀哲 、柴田悠貴 、藤本政毅 、鈴木基史 、東川桂 、宮本 直樹 、稲波修 、久下裕司
    • Organizer
      日本放射線影響学会第63回大会
    • Related Report
      2020 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi